Cargando…
Halofuginone and artemisinin synergistically arrest cancer cells at the G1/G0 phase by upregulating p21(Cip1) and p27(Kip1)
Combinational drug therapy is one of the most promising strategies in modern anticancer research. Traditional Chinese medicine (TCM) formulas represent a wealth of complex combinations proven successful over centuries of clinical application. One such formula used to treat a variety of diseases, inc...
Autores principales: | Chen, Guoqing, Gong, Ruihong, Shi, Xianli, Yang, Dajian, Zhang, Ge, Lu, Aiping, Yue, Jianbo, Bian, Zhaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226584/ https://www.ncbi.nlm.nih.gov/pubmed/27385212 http://dx.doi.org/10.18632/oncotarget.10367 |
Ejemplares similares
-
TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer
por: Meyer, Rosana D., et al.
Publicado: (2017) -
p27(Kip1) and p21(Cip1) collaborate in the regulation of transcription by recruiting cyclin–Cdk complexes on the promoters of target genes
por: Orlando, Serena, et al.
Publicado: (2015) -
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis
por: Zhang, Shu, et al.
Publicado: (2015) -
Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21(Cip1) and p27(Kip1)
por: Jee, Hyang, et al.
Publicado: (2013) -
p27(Kip1) and Ser10-phosphorylated p27(Kip1) in breast cancer: clinical significance and expression
por: Song, Wei, et al.
Publicado: (2015)